{
  "id": "acf6a7d0bb9431c3",
  "title": "STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer\u2019s",
  "description": "Why Bristol Myers Squibb is banking on a decades-old drug to help secure its future.",
  "content": "Why Bristol Myers Squibb is banking on a decades-old drug to help secure its future.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/02/bristol-myers-squibb-facing-patent-cliff-big-bet-on-cobenfy/?utm_campaign=rss",
  "published_at": "2026-02-02T09:30:00+00:00",
  "fetched_at": "2026-02-03T00:29:56.519436+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "bank",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer\u2019s",
    "description": "Why Bristol Myers Squibb is banking on a decades-old drug to help secure its future.",
    "url": "https://www.statnews.com/2026/02/02/bristol-myers-squibb-facing-patent-cliff-big-bet-on-cobenfy/?utm_campaign=rss",
    "published": "2026-02-02T09:30:00+00:00",
    "source": "STAT"
  }
}